Definitive Contract 75N93023C00032
Award Date 9/30/23
Potential Completion Date 9/29/24
Potential Value $300K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Lafayette, IN 47907, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases to Teichos Laboratories, LLC, a small business located in West Lafayette, IN. The $300,000 firm fixed price contract is for research on a novel TLR2 agonist-aluminum combination adjuvant to improve the quality and duration of the immune response. This SBIR contract was awarded under a solicitation that sought innovative...
- The Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $599,980 firm fixed price contract to Tendel Therapies, Inc., a small business, for research and development services related to genetic adjuvants to promote durable anti-influenza stem antibodies in older adults. This contract was awarded under the NIH and Centers for Disease Control and Prevention's Small Business Innovation Research (SBIR) program,...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $4,148,210.00 Firm Fixed Price Definitive Contract to Metaclipse Therapeutics Corp, a self-certified small disadvantaged business, for the development of membrane-anchored cytokines as novel vaccine adjuvants for the elderly. This contract, which has a completion date of December 31, 2022, is part of the agency's "DEVELOPMENT OF MEMBRANE ANCHORED...
- This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Adjuvance Technologies Inc. for the preclinical development of a semisynthetic saponin immunological adjuvant called Titerquil-1055 in the context of an influenza vaccine. The contract is a definitive, firm-fixed-price contract with a potential value of $1,471,319.00 and a completion date of December 15, 2020. The contract is...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Tolka.ai Inc. (doing business as Tolka AI Therapeutics), a for-profit small business. The contract, valued at $299,993.00, is for research and development efforts related to NIAID's mission needs and SBIR program objectives. The original solicitation included a variety of research topics,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $599,582.00 firm fixed price contract to Virtici LLC, a for-profit limited liability company, to develop toll-like receptor agonists to strengthen sublingual vaccines. This contract is a small business set-aside. Virtici LLC is a biomedical research and development company that has received over $3 million in prior federal contracts and grants from agencies...
- Leidos, Inc. was awarded an $11.02 million cost-plus-fixed-fee definitive contract by the National Institute of Allergy and Infectious Diseases (NIAID) on September 30, 2013, for biomedical basic research support under the Adjuvant Development Program. The contract, with performance in West McLean, Virginia, and an ultimate completion date of June 30, 2021, involves the development of vaccine adjuvants to enhance immunological responses. The award carries no set-aside designation, reflecting...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order contract to Advanced Bioadjuvants, LLC, a self-certified small disadvantaged business. The contract is for license fees related to the Adjuplex trademark, patents, and trade secret manufacturing process, which NIAID will use to combine with human vaccines for clinical trials. The contract has a 12-month...
- Hafion Inc., a self-certified small disadvantaged and woman-owned small business, was awarded a $310,592 Firm Fixed Price Definitive Contract from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS NIH NIAID) under the HHS SBIR Program. The contract, which was set aside for small businesses, is for research and development services related to the development of protein:non-protein macromolecular adjuvants. The...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price definitive contract valued at $585,999.00 to Protein Innovation Labs, Inc., a small business concern, for the provision of reagents to support immunologic analysis of non-mammalian models. This contract was awarded under the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) Small Business Innovation...